NCT06636578View on ClinicalTrials.gov

Dexmedetomidine Ropivacaine Versus Plain Ropivacaine in Bilateral Pectoralis Nerve (PECS) Block

PHASE4RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 10, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

January 8, 2025

Conditions
Analgesia
Interventions
DRUG

dexmedetomidine

will receive 30 ml of 0.25% of ropivacaine + dexmedetomidine 0.5 μg/kg for each side.

DRUG

ropivacaine

will receive 30 ml of 0.25% of plain ropivacaine for each side.

DRUG

fentanyl

will not receive any regional anesthesia and only will receive I.V. fentanyl 1μg/kg/hr.

Trial Locations (2)

63511

COMPLETED

Fayoum University Hospital, Al Fayyum

RECRUITING

Mohamed Hamed, Al Fayyum

All Listed Sponsors
lead

Fayoum University

OTHER